VAM
WST icon

Visium Asset Management’s West Pharmaceutical WST Stock Holding History

Visium Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,355
Closed -$655K – 1044
2013
Q4 		$655K Sell
13,355
-1,193
-8% -$55.8K 0.01% 536
2013
Q3 		$599K Buy
14,548
+1,980
+16% +$75.5K 0.01% 508
2013
Q2 		$442K Buy
+12,568
New +$414K 0.01% 505

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Visium Asset Management's WST Position: Q1 2014 in Review

Visium Asset Management sold out of West Pharmaceutical (WST) in Q1 2014, closing a stake of 13,355 shares — an estimated $655K sold.

Visium Asset Management first reported a position in WST in Q2 2013 and held it in 3 quarters. The position peaked at $655K in Q4 2013. 226 funds tracked by Wall St. Rank hold WST as of Q1 2014.

  • Visium Asset Management reported no remaining West Pharmaceutical position as of Q1 2014 after selling out during the quarter.
  • Visium Asset Management sold 13,355 West Pharmaceutical shares in Q1 2014, an estimated $655K.
  • Visium Asset Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 3 quarters.
  • Visium Asset Management's West Pharmaceutical position peaked at $655K in Q4 2013.
  • 226 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2014.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.